Site Not Found
The Gene Therapy Program at the University of Pennsylvania transitioned its activities to Gemma Biotherapeutics (GEMMABio) and Franklin Biolabs on October 1, 2024.
The Gene Therapy Program at the University of Pennsylvania transitioned its activities to Gemma Biotherapeutics (GEMMABio) and Franklin Biolabs on October 1, 2024.